Athira pharma reports full year 2024 financial results and pipeline and business updates

Completed healthy volunteer phase 1 clinical study of ath-1105 as a potential treatment for amyotrophic lateral sclerosis (als)

ATHA Ratings Summary

ATHA Quant Ranking